Cefazolin is an antibiotic used to prevent infections during surgery. In this clinical trial, researchers are studying how the levels of a protein in the blood, called albumin, affect how the body processes this medication. Cefazolin is given to patients undergoing heart surgery to help prevent infections, and the study aims to understand how different levels of albumin might change the way the drug works in the body.

Heart Disease – Heart disease refers to a range of conditions affecting the heart’s structure and function. It often involves narrowed or blocked blood vessels, which can lead to chest pain or heart attacks. Over time, heart disease can cause the heart to weaken, affecting its ability to pump blood efficiently. This can result in symptoms such as shortness of breath, fatigue, and swelling in the legs or abdomen. The progression of heart disease can vary, with some individuals experiencing rapid changes, while others may have a more gradual development of symptoms. Lifestyle factors, such as diet and exercise, can influence the progression of heart disease.

Hypoalbuminemia – Hypoalbuminemia is a condition characterized by low levels of albumin in the blood. Albumin is a protein produced by the liver, and it plays a crucial role in maintaining the osmotic pressure needed for proper distribution of body fluids. When albumin levels drop, fluid can leak out of blood vessels, leading to swelling, particularly in the legs and abdomen. This condition can develop due to various factors, including liver disease, kidney problems, or malnutrition. As hypoalbuminemia progresses, it can affect the body’s ability to transport hormones, vitamins, and drugs. The severity and progression depend on the underlying cause and the body’s response to it.